Great Expectations: Private Sector Activity in Tissue Engineering, Regenerative Medicine, and Stem Cell Therapeutics

2008 ◽  
Vol 14 (2) ◽  
pp. 305-315 ◽  
Author(s):  
Michael J. Lysaght ◽  
Ana Jaklenec ◽  
Elizabeth Deweerd
Keyword(s):  
Tissue Engineering ◽  
Stem Cell ◽  
Regenerative Medicine ◽  
Private Sector ◽  
Great Expectations ◽  
Cell Therapeutics ◽  
Stem Cell Therapeutics

REGENERATIVE MEDICINE AND STEM CELL THERAPEUTICS

2009 ◽  
pp. 1317-1331 ◽  
Author(s):  
Timothy J. Nelson ◽  
Atta Behfar ◽  
Andre Terzic
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Cell Therapeutics ◽  
Stem Cell Therapeutics

scholarly journals Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine

2016 ◽  
Vol 23 (8) ◽  
pp. 893-916 ◽  
Author(s):  
Kai Liu ◽  
Chen Yu ◽  
Min Xie ◽  
Ke Li ◽  
Sheng Ding
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Cell Fate ◽  
Cell Therapeutics ◽  
Chemical Modulation ◽  
Stem Cell Therapeutics

scholarly journals Recent advances in stem cell therapeutics and tissue engineering strategies

2018 ◽  
Vol 22 (1) ◽  
Author(s):  
Seong Gyu Kwon ◽  
Yang Woo Kwon ◽  
Tae Wook Lee ◽  
Gyu Tae Park ◽  
Jae Ho Kim
Keyword(s):  
Tissue Engineering ◽  
Stem Cell ◽  
Cell Therapeutics ◽  
Recent Advances ◽  
Stem Cell Therapeutics

scholarly journals Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics

Cell Reports ◽  
2017 ◽  
Vol 20 (8) ◽  
pp. 1978-1990 ◽  
Author(s):  
Nigel G. Kooreman ◽  
Patricia E. de Almeida ◽  
Jonathan P. Stack ◽  
Raman V. Nelakanti ◽  
Sebastian Diecke ◽  
...  
Keyword(s):  
Stem Cell ◽  
Pluripotent Stem Cell ◽  
Humanized Mice ◽  
Human Pluripotent Stem Cell ◽  
Cell Therapeutics ◽  
Stem Cell Therapeutics

scholarly journals Regenerative medicine: the emergence of an industry

2010 ◽  
Vol 7 (suppl_6) ◽  
Author(s):  
Robert M. Nerem
Keyword(s):  
Tissue Engineering ◽  
Regenerative Medicine ◽  
Private Sector ◽  
Medical Device ◽  
Engineering Industry ◽  
Full Time ◽  
Business Units ◽  
The World ◽  
The Future ◽  
Pharmaceutical Industries

Over the last quarter of a century there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. There have been ‘ups and downs’ in this industry; however, it now appears to be on a track that may be described as ‘back to the future’. The latest data indicate that for 2007 the private sector activity in the world for this industry is approaching $2.5 billion, with 167 companies/business units and more than 6000 employee full time equivalents. Although small compared with the medical device and also the pharmaceutical industries, these numbers are not insignificant. Thus, there is the indication that this industry, and the related technology, may still achieve its potential and address the needs of millions of patients worldwide, in particular those with needs that currently are unmet.

Developing Stem Cell Therapeutics for the Heart also Requires Targeting Non-myocytes

2013 ◽  
Vol 22 (12) ◽  
pp. 975-979
Author(s):  
Jeffrey Y.J. Looi ◽  
Ngaire J. Elwood ◽  
Christian P. Brizard ◽  
Salvatore Pepe
Keyword(s):  
Stem Cell ◽  
Cell Therapeutics ◽  
Stem Cell Therapeutics
Sign in / Sign up

Export Citation Format

Share Document